Much of the world's population had already been infected with COVID-19 by the time the Omicron variant emerged at the end of 2021, but the scale of the Omicron wave was larger than any that had come before or has happened since, and it left a global imprinting of immunity that changed the COVID-19 landscape. In this study, we simulate a South African population and demonstrate how population-level vaccine effectiveness and efficiency changed over the course of the first 2 years of the pandemic. We then introduce three hypothetical variants and evaluate the impact of vaccines with different properties. We find that variant-chasing vaccines have a narrow window of dominating pre-existing vaccines but that a variant-chasing vaccine strategy may have global utility, depending on the rate of spread from setting to setting. Next-generation vaccines might be able to overcome uncertainty in pace and degree of viral evolution.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015104 | PMC |
http://dx.doi.org/10.1016/j.celrep.2023.112308 | DOI Listing |
Vet Clin North Am Food Anim Pract
December 2024
Clinical Sciences, Auburn University, Auburn, AL, USA; Department of Clinical Sciences, Auburn University College of Veterinary Medicine, 1500 Wire Road, Auburn, AL 36849, USA. Electronic address:
This article addresses infectious reproductive diseases in cattle, which can significantly impact production and profit on cattle operations. It highlights vital biosecurity practices aimed at minimizing the introduction of reproductive pathogens into breeding herds, including the importance of maintaining records, implementing a defined breeding season, culling nonproductive animals, quarantining and testing imported livestock, and the use of vaccines to maximize herd immunity. The article focuses on economically important reproductive pathogens of cattle from a biosecurity standpoint, focusing on mitigating the introduction and impact of reproductive diseases in cattle.
View Article and Find Full Text PDFOral Dis
December 2024
Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
Objective: Oral tongue squamous cell carcinoma is an aggressive life-threatening disease, the prognosis of which is affected by tumor stage and size. We retrospectively studied whether oral inflammatory burden and established tongue carcinoma etiological factors exert an impact on tumor size and stage.
Materials And Methods: Medical records of 183 subjects diagnosed with tongue carcinoma at Helsinki University Hospital were investigated.
J Med Virol
January 2025
Department of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 pandemic, has resulted in over 7 million confirmed deaths. In addition to severe respiratory and systematic symptoms, several comorbidities increase the risk of fatal outcomes. Therefore, it is essential to investigate the impact of COVID-19 on pre-existing conditions in patients, such as cancer and other infectious diseases.
View Article and Find Full Text PDFPLOS Glob Public Health
December 2024
Cancer Control and Population Sciences, Comprehensive Cancer Center, University of Puerto Rico, San Juan, Puerto Rico.
This study evaluates the association between immunization program (IP) activities aimed at increasing HPV vaccination among adolescents and their impact on initiation rates. Our data sources are: (i) 2016 AIM Annual Survey and (ii) 2019 National Immunization Survey-Teen. We estimated the prevalence of HPV vaccine initiation using a multilevel Poisson model, combining state-level IP data and individual characteristics of adolescents.
View Article and Find Full Text PDFClin Transplant
January 2025
Gastro-Intestinal Rehabilitation and Transplant Center - GIRTC, Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Background: There has been significant concern about coronavirus disease 2019 (COVID-19) among transplant recipients, particularly those who are highly immunosuppressed. Several studies have analyzed the impact of COVID-19 on different solid organ transplant patients. However, few isolated case reports of COVID-19 in intestinal and multivisceral transplant (ITx and MVTx) recipients are available in the literature.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!